Back to Authors

Hajduch, Marian

0000-0002-4834-908X

Mayo Clinic

Institute of Molecular and Translational Medicine

Citations 2

Missorting of plasma miRNAs in aging and Alzheimer's disease
Čarná, Mária , Novotný, Jan , Dragišić, Neda, Slavík, Hanuš , Sheardová, Kateřina , Geda, Yonas E. , Laczó, Jan , Hort, Jakub , Mao, Zixu , Dammer, Eric B. , Novotny, Jan S , Vyhnalek, Martin , Hort, Jakub , Mao, Zixu , Rissman, Robert A. , Hajduch, Marian , Dammer, Eric B , Stokin, Gorazd , Geda, Yonas E , Vyhnálek, Martin , Stokin, Gorazd B.

Journal of Neurochemistry | March 9, 2023 | Volume: 165 | Issue: 2 | Pages: 149-161

10.1111/jnc.15801 Get It

Abstract The observation that aging is regulated by microRNAs (miRNA) and at the same time represents the greatest risk factor for Alzheimer's disease (AD), prompted us to examine the circulating miRNA network in AD beyond aging. We here show that plasma miRNAs in aging are downregulated and predicted to be preferentially targeted to the extracellular vesicle (EV) content. In AD, miRNAs are further downregulated, display altered proportions of motifs relevant to their loading into EVs and secretion propensity, and are forecast to be found exclusively in EVs. The circulating miRNA network in AD, therefore, reflects pathological exacerbation of the aging process whereby physiological suppression of AD pathology by miRNAs becomes insufficient. image
Pathogenesis of Alzheimer's disease: Involvement of the choroid plexus
Čarná, Mária , Onyango, Isaac G. , Katina, Stanislav , Holub, Dušan , Nezvedová, Markéta , Jha, Durga , Nedelská, Zuzana , Lacovich, Valentina , Houbrechts, Ruben, Garcia‐Mansfield, Krystine , David‐Dirgo, Victoria , Texlova, Kateřina, Bakkar, Nadine , Pertierra, Lucía , Vinkler, Mojmír, Marková, Hana, Laczó, Jan , Kohoutková, Marcela Hortová , Frič, Jan , Forte, Giancarlo , Bělašková, Silvie , Seyfried, Nicholas T. , Bowser, Robert , Pirrotte, Patrick , Dammer, Eric B. , Limbäck‐Stokin, Clara, Stokin, Gorazd B. , Nedelska, Zuzana , Dammer, Eric B , Novotný, Jan , Vyvere, Thijs Vande , Sharma, Ritin , Vyhnálek, Martin , Chaves, Hernán , Sheardová, Kateřina , Kaňovský, Petr , Damborský, Jiřı́ , Hort, Jakub , Sevlever, Gustavo Emilio , Rissman, Robert A. , Smith, Richard Alan , Hajduch, Marian , Spáčil, Zdeněk

Alzheimer's & Dementia | February 24, 2023 | Volume: 19 | Issue: 8 | Pages: 3537-3554

10.1002/alz.12970 Get It

Abstract The choroid plexus (ChP) produces and is bathed in the cerebrospinal fluid (CSF), which in aging and Alzheimer's disease (AD) shows extensive proteomic alterations including evidence of inflammation. Considering inflammation hampers functions of the involved tissues, the CSF abnormalities reported in these conditions are suggestive of ChP injury. Indeed, several studies document ChP damage in aging and AD, which nevertheless remains to be systematically characterized. We here report that the changes elicited in the CSF by AD are consistent with a perturbed aging process and accompanied by aberrant accumulation of inflammatory signals and metabolically active proteins in the ChP. Magnetic resonance imaging (MRI) imaging shows that these molecular aberrancies correspond to significant remodeling of ChP in AD, which correlates with aging and cognitive decline. Collectively, our preliminary post‐mortem and in vivo findings reveal a repertoire of ChP pathologies indicative of its dysfunction and involvement in the pathogenesis of AD. Highlights Cerebrospinal fluid changes associated with aging are perturbed in Alzheimer's disease Paradoxically, in Alzheimer's disease, the choroid plexus exhibits increased cytokine levels without evidence of inflammatory activation or infiltrates In Alzheimer's disease, increased choroid plexus volumes correlate with age and cognitive performance